The National Institutes of Health (NIH) Scientific Workshop on Violence & Related Health Outcomes in Sexual & Gender Minority Communities Open Session, 40863-40864 [2021-16190]

Download as PDF Federal Register / Vol. 86, No. 143 / Thursday, July 29, 2021 / Notices 93.393, Cancer Cause and Prevention Research; 93.394, Cancer Detection and Diagnosis Research; 93.395, Cancer Treatment Research; 93.396, Cancer Biology Research; 93.397, Cancer Centers Support; 93.398, Cancer Research Manpower; 93.399, Cancer Control, National Institutes of Health, HHS) Dated: July 26, 2021. Melanie J. Pantoja, Program Analyst, Office of Federal Advisory Committee Policy. [FR Doc. 2021–16162 Filed 7–28–21; 8:45 am] DEPARTMENT OF HEALTH AND HUMAN SERVICES National Institutes of Health The National Institutes of Health (NIH) Scientific Workshop on Violence & Related Health Outcomes in Sexual & Gender Minority Communities Open Session AGENCY: ACTION: BILLING CODE 4140–01–P National Institutes of Health, HHS. Notice. The National Institutes of Health (NIH) will hold the Phase IV open session for the NIH Scientific Workshop on Violence and Related Health Outcomes in Sexual and Gender Minority (SGM) Communities to enhance our understanding of violence against SGM individuals and identify opportunities in violence-related research. The primary objectives of NIH’s Phase IV meeting are: (1) To allow the public to participate, and (2) to further refine research opportunities. DATES: The NIH Scientific Workshop on Violence and Related Health Outcomes in Sexual and Gender Minority Communities Phase IV virtual meeting will be held on Thursday, August 26, 2021, from 12:00–4:00 p.m. Eastern Daylight Time (New York, GMT). ADDRESSES: The meeting will be held virtually via WebEx. The preliminary agenda and registration are available at https:// tinyurl.com/SGMwkshp. FOR FURTHER INFORMATION CONTACT: Irene Avila, Ph.D., Assistant Director, Sexual & Gender Minority Research Office (SGMRO), avilai@mail.nih.gov, 301–594–9701. SUPPLEMENTARY INFORMATION: Background: ‘‘Sexual and gender minority’’ is an umbrella term that includes, but is not limited to, individuals who identify as lesbian, gay, bisexual, asexual, transgender, TwoSpirit, queer, and/or intersex. Individuals with same-sex or -gender attractions or behaviors and those with a difference in sex development are also included. These populations also encompass those who do not selfidentify with one of these terms but whose sexual orientation, gender identity or expression, or reproductive development is characterized by nonbinary constructs of sexual orientation, gender, and/or sex. In accordance with Section 404N of the 21st Century Cures Act (Pub. L. 114– 255), the Director of NIH shall encourage research on SGM populations. The Sexual and Gender Minority Research Office (SGMRO) SUMMARY: DEPARTMENT OF HEALTH AND HUMAN SERVICES National Institutes of Health National Institute of Biomedical Imaging and Bioengineering; Notice of Closed Meeting Pursuant to section 10(d) of the Federal Advisory Committee Act, as amended, notice is hereby given of a meeting of the National Institute of Biomedical Imaging and Bioengineering Special Emphasis Panel. The meetings will be closed to the public in accordance with the provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5 U.S.C., as amended. The grant applications and the discussions could disclose confidential trade secrets or commercial property such as patentable material, and personal information concerning individuals associated with the grant applications, the disclosure of which would constitute a clearly unwarranted invasion of personal privacy. jbell on DSKJLSW7X2PROD with NOTICES Name of Committee: National Institute of Biomedical Imaging and Bioengineering Special Emphasis Panel; P41 NCBIB Review F–SEP. Date: October 25–26, 2021. Time: 09:00 a.m. to 4:30 p.m. Agenda: To review and evaluate grant applications. Place: National Institutes of Health, Democracy II, 6707 Democracy Blvd., Bethesda, MD 20892 (Virtual Meeting). Contact Person: Dennis Hlasta, Ph.D., Scientific Review Officer, National Institute of Biomedical Imaging and Bioengineering, National Institutes of Health, 6707 Democracy Blvd., Bethesda, MD 20892, (301) 451–3398, dennis.hlasta@mail.nih.gov. (Catalogue of Federal Domestic Assistance Program Nos. 93.866, National Institute of Biomedical Imaging and Bioengineering, National Institutes of Health, HHS) Dated: July 23, 2021. David W. Freeman, Program Analyst, Office of Federal Advisory Committee Policy. [FR Doc. 2021–16161 Filed 7–28–21; 8:45 am] BILLING CODE 4140–01–P VerDate Sep<11>2014 19:19 Jul 28, 2021 Jkt 253001 PO 00000 Frm 00062 Fmt 4703 Sfmt 4703 40863 coordinates SGM-related research and activities by working directly with NIH Institutes, Centers, and Offices. The Office was officially established in September 2015 within the Division of Program Coordination, Planning, and Strategic Initiatives (DPCPSI) in the NIH Office of the Director and has the following operational goals: (1) Advance rigorous research on the health of SGM populations in both the extramural and intramural research communities; (2) expand SGM health research by fostering partnerships and collaborations with a strategic array of internal and external stakeholders; (3) foster a highly skilled and diverse workforce in SGM health research; and (4) encourage data collection related to SGM populations in research and the biomedical research workforce. The Scientific Workshop on Violence and Related Health Outcomes in Sexual and Gender Minority Communities represents an important step in pursuing these goals specifically in the field of violence research. The NIH Scientific Workshop on Violence and Related Health Outcomes in Sexual and Gender Minority Communities Phase IV Public Meeting Details The NIH Scientific Workshop on Violence and Related Health Outcomes in Sexual and Gender Minority Communities invites stakeholders throughout the scientific research community, clinical practice communities, patient and family advocates, scientific or professional organizations, federal partners, internal NIH stakeholders, and other interested members of the public to participate and provide comments, questions, or feedback at the workshop. The goal of the meeting is to identify opportunities in violence-related research. Public input will serve as a valuable element in the development of the final proposed research opportunities. This notice serves as the announcement for the fourth and final phase of the Scientific Workshop on Violence and Related Health Outcomes in Sexual and Gender Minority Communities. Phase I was the Request for Information (RFI) https:// www.federalregister.gov/documents/ 2020/11/25/2020-26094/request-forinformation-on-research-opportunitiesrelated-to-the-national-institutes-ofhealth published in November 2020. The summary of the comments received can be found on the https:// dpcpsi.nih.gov/sgmro website. Phase II was a session on the state of the science for violence research affecting SGM communities (a recording will be E:\FR\FM\29JYN1.SGM 29JYN1 40864 Federal Register / Vol. 86, No. 143 / Thursday, July 29, 2021 / Notices available after August 26, 2021). The meeting applied an ecological model focusing on family of origin abuse across the lifespan, victimization by peers and friends, romantic and sexual partner violence, and community violence. Phase III included working groups to identify and describe research opportunities to further understand the role of violence in the health of SGM individuals. The working groups were comprised of these five domains: • Demographics and Epidemiology • Risk Factors and Pathways • Preventive Interventions • Treatment-focused Interventions • Ethics and Logistical Challenges Phase IV will involve moderated discussions with the presenters from the Phase III working groups to refine research opportunities needed to further our understanding of violence in SGM communities. Audience feedback, comments, and questions during this session will help further refine the proposed research opportunities. Dated: July 21, 2021. Lawrence A. Tabak, Principal Deputy Director, National Institutes of Health. [FR Doc. 2021–16190 Filed 7–28–21; 8:45 am] BILLING CODE 4140–01–P National Institutes of Health Center for Scientific Review; Notice of Closed Meeting jbell on DSKJLSW7X2PROD with NOTICES Pursuant to section 10(d) of the Federal Advisory Committee Act, as amended, notice is hereby given of the following meeting. The meeting will be closed to the public in accordance with the provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5 U.S.C., as amended. The grant applications and the discussions could disclose confidential trade secrets or commercial property such as patentable material, and personal information concerning individuals associated with the grant applications, the disclosure of which would constitute a clearly unwarranted invasion of personal privacy. Name of Committee: Center for Scientific Review Special Emphasis Panel; Signaling and Molecular Endocrinology. Date: August 23, 2021. Time: 3:00 p.m. to 5:00 p.m. Agenda: To review and evaluate grant applications. Place: National Institutes of Health, Rockledge II, 6701 Rockledge Drive, Bethesda, MD 20892 (Telephone Conference Call). 19:19 Jul 28, 2021 Jkt 253001 (Catalogue of Federal Domestic Assistance Program Nos. 93.306, Comparative Medicine; 93.333, Clinical Research, 93.306, 93.333, 93.337, 93.393–93.396, 93.837–93.844, 93.846–93.878, 93.892, 93.893, National Institutes of Health, HHS) Dated: July 23, 2021. Tyeshia M. Roberson-Curtis, Program Analyst, Office of Federal Advisory Committee Policy. [FR Doc. 2021–16112 Filed 7–28–21; 8:45 am] BILLING CODE 4140–01–P DEPARTMENT OF HOMELAND SECURITY U.S. Customs and Border Protection [CBP Dec. 21–12] COBRA Fees To Be Adjusted for Inflation in Fiscal Year 2022 U.S. Customs and Border Protection, Department of Homeland Security. ACTION: General notice. AGENCY: This document announces that U.S. Customs and Border Protection (CBP) is adjusting certain customs user fees and corresponding limitations established by the Consolidated Omnibus Budget Reconciliation Act (COBRA) for Fiscal Year 2022 in accordance with the Fixing America’s Surface Transportation Act (FAST Act) as implemented by the CBP regulations. DATES: The adjusted amounts of customs COBRA user fees and their corresponding limitations set forth in this notice for Fiscal Year 2022 are required as of October 1, 2021. FOR FURTHER INFORMATION CONTACT: Tina Ghiladi, Senior Advisor, International Travel & Trade, Office of Finance, 202– 344–3722, UserFeeNotices@cbp.dhs.gov. SUPPLEMENTARY INFORMATION: SUMMARY: DEPARTMENT OF HEALTH AND HUMAN SERVICES VerDate Sep<11>2014 Contact Person: Latha Meenalochana Malaiyandi, Ph.D. Scientific Review Officer, Center for Scientific Review, National Institutes of Health, 6701 Rockledge Drive, Room 812Q, Bethesda, MD 20892, (301) 435– 1999, malaiyandilm@csr.nih.gov. I. Background A. Adjustments of COBRA User Fees and Corresponding Limitations for Inflation On December 4, 2015, the Fixing America’s Surface Transportation Act (FAST Act, Pub. L. 114–94) was signed into law. Section 32201 of the FAST Act amended section 13031 of the Consolidated Omnibus Budget Reconciliation Act (COBRA) of 1985 (19 U.S.C. 58c) by requiring the Secretary of the Treasury (Secretary) to adjust certain PO 00000 Frm 00063 Fmt 4703 Sfmt 4703 customs COBRA user fees and corresponding limitations to reflect certain increases in inflation. Sections 24.22 and 24.23 of title 19 of the Code of Federal Regulations (19 CFR 24.22 and 24.23) describe the procedures that implement the requirements of the FAST Act. Specifically, paragraph (k) in § 24.22 (19 CFR 24.22(k)) sets forth the methodology to determine the change in inflation as well as the factor by which the fees and limitations will be adjusted, if necessary. The fees and limitations subject to adjustment, which are set forth in appendix A and appendix B of part 24, include the commercial vessel arrival fees, commercial truck arrival fees, railroad car arrival fees, private vessel arrival fees, private aircraft arrival fees, commercial aircraft and vessel passenger arrival fees, dutiable mail fees, customs broker permit user fees, barges and other bulk carriers arrival fees, and merchandise processing fees, as well as the corresponding limitations. B. Determination of Whether an Adjustment Is Necessary for Fiscal Year 2022 In accordance with 19 CFR 24.22, CBP must determine annually whether the fees and limitations must be adjusted to reflect inflation. For Fiscal Year 2022, CBP is making this determination by comparing the average of the Consumer Price Index—All Urban Consumers, U.S. All items, 1982–1984 (CPI–U) for the current year (June 2020–May 2021) with the average of the CPI–U for the comparison year (June 2019–May 2020) to determine the change in inflation, if any. If there is an increase in the CPI– U of greater than one (1) percent, CBP must adjust the customs COBRA user fees and corresponding limitations using the methodology set forth in 19 CFR 24.22(k). Following the steps provided in paragraph (k)(2) of § 24.22, CBP has determined that the increase in the CPI–U between the most recent June to May twelve-month period (June 2020–May 2021) and the comparison year (June 2019–May 2020) is 1.94 1 percent. As the increase in the CPI–U is greater than one (1) percent, the customs COBRA user fees and corresponding limitations must be adjusted for Fiscal Year 2022. 1 The figures provided in this notice may be rounded for publication purposes only. The calculations for the adjusted fees and limitations were made using unrounded figures, unless otherwise noted. E:\FR\FM\29JYN1.SGM 29JYN1

Agencies

[Federal Register Volume 86, Number 143 (Thursday, July 29, 2021)]
[Notices]
[Pages 40863-40864]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2021-16190]


-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

National Institutes of Health


The National Institutes of Health (NIH) Scientific Workshop on 
Violence & Related Health Outcomes in Sexual & Gender Minority 
Communities Open Session

AGENCY: National Institutes of Health, HHS.

ACTION: Notice.

-----------------------------------------------------------------------

SUMMARY: The National Institutes of Health (NIH) will hold the Phase IV 
open session for the NIH Scientific Workshop on Violence and Related 
Health Outcomes in Sexual and Gender Minority (SGM) Communities to 
enhance our understanding of violence against SGM individuals and 
identify opportunities in violence-related research. The primary 
objectives of NIH's Phase IV meeting are: (1) To allow the public to 
participate, and (2) to further refine research opportunities.

DATES: The NIH Scientific Workshop on Violence and Related Health 
Outcomes in Sexual and Gender Minority Communities Phase IV virtual 
meeting will be held on Thursday, August 26, 2021, from 12:00-4:00 p.m. 
Eastern Daylight Time (New York, GMT).

ADDRESSES: The meeting will be held virtually via WebEx.
    The preliminary agenda and registration are available at https://tinyurl.com/SGMwkshp.

FOR FURTHER INFORMATION CONTACT: Irene Avila, Ph.D., Assistant 
Director, Sexual & Gender Minority Research Office (SGMRO), 
[email protected], 301-594-9701.

SUPPLEMENTARY INFORMATION: 
    Background: ``Sexual and gender minority'' is an umbrella term that 
includes, but is not limited to, individuals who identify as lesbian, 
gay, bisexual, asexual, transgender, Two-Spirit, queer, and/or 
intersex. Individuals with same-sex or -gender attractions or behaviors 
and those with a difference in sex development are also included. These 
populations also encompass those who do not self-identify with one of 
these terms but whose sexual orientation, gender identity or 
expression, or reproductive development is characterized by non-binary 
constructs of sexual orientation, gender, and/or sex.
    In accordance with Section 404N of the 21st Century Cures Act (Pub. 
L. 114-255), the Director of NIH shall encourage research on SGM 
populations. The Sexual and Gender Minority Research Office (SGMRO) 
coordinates SGM-related research and activities by working directly 
with NIH Institutes, Centers, and Offices. The Office was officially 
established in September 2015 within the Division of Program 
Coordination, Planning, and Strategic Initiatives (DPCPSI) in the NIH 
Office of the Director and has the following operational goals: (1) 
Advance rigorous research on the health of SGM populations in both the 
extramural and intramural research communities; (2) expand SGM health 
research by fostering partnerships and collaborations with a strategic 
array of internal and external stakeholders; (3) foster a highly 
skilled and diverse workforce in SGM health research; and (4) encourage 
data collection related to SGM populations in research and the 
biomedical research workforce. The Scientific Workshop on Violence and 
Related Health Outcomes in Sexual and Gender Minority Communities 
represents an important step in pursuing these goals specifically in 
the field of violence research.

The NIH Scientific Workshop on Violence and Related Health Outcomes in 
Sexual and Gender Minority Communities Phase IV Public Meeting Details

    The NIH Scientific Workshop on Violence and Related Health Outcomes 
in Sexual and Gender Minority Communities invites stakeholders 
throughout the scientific research community, clinical practice 
communities, patient and family advocates, scientific or professional 
organizations, federal partners, internal NIH stakeholders, and other 
interested members of the public to participate and provide comments, 
questions, or feedback at the workshop. The goal of the meeting is to 
identify opportunities in violence-related research. Public input will 
serve as a valuable element in the development of the final proposed 
research opportunities.
    This notice serves as the announcement for the fourth and final 
phase of the Scientific Workshop on Violence and Related Health 
Outcomes in Sexual and Gender Minority Communities. Phase I was the 
Request for Information (RFI) https://www.federalregister.gov/documents/2020/11/25/2020-26094/request-for-information-on-research-opportunities-related-to-the-national-institutes-of-health published in 
November 2020. The summary of the comments received can be found on the 
https://dpcpsi.nih.gov/sgmro website. Phase II was a session on the 
state of the science for violence research affecting SGM communities (a 
recording will be

[[Page 40864]]

available after August 26, 2021). The meeting applied an ecological 
model focusing on family of origin abuse across the lifespan, 
victimization by peers and friends, romantic and sexual partner 
violence, and community violence. Phase III included working groups to 
identify and describe research opportunities to further understand the 
role of violence in the health of SGM individuals. The working groups 
were comprised of these five domains:

 Demographics and Epidemiology
 Risk Factors and Pathways
 Preventive Interventions
 Treatment-focused Interventions
 Ethics and Logistical Challenges

    Phase IV will involve moderated discussions with the presenters 
from the Phase III working groups to refine research opportunities 
needed to further our understanding of violence in SGM communities. 
Audience feedback, comments, and questions during this session will 
help further refine the proposed research opportunities.

    Dated: July 21, 2021.
Lawrence A. Tabak,
Principal Deputy Director, National Institutes of Health.
[FR Doc. 2021-16190 Filed 7-28-21; 8:45 am]
BILLING CODE 4140-01-P